Reduced Ia-afferent-mediated Hoffman reflex in streptozotocin-induced diabetic rats

Experimental Neurology

Volumn 172, Issue 1, 2001, Pages 220-227

  Tonra, James R ^a   Cliffer, Kenneth D ^a   Carson, Susan R ^a   Lindsay, Ronald M ^a   Bodine, Sue C ^a   DiStefano, Peter S ^a  

^a REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Diabetes; Muscle atrophy; Neuropathy; Stz; Tendon reflex

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTROPHYSIOLOGY; FEMALE; HOFFMANN REFLEX; MUSCLE ACTION POTENTIAL; MUSCLE ATROPHY; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; TENDON REFLEX;

EID: 0035214206     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7767     Document Type: Article

References (45)

1. Muscular atrophy in diabetic neuropathy: A stereological magnetic resonance imaging study
2. Nerve biopsy and conduction studies in diabetic neuropathy
3. Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat
4. Consistent repeated M- and H-wave recording in the hind limb of rats
5. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
7. An aid to the electrophysiological diagnosis of diabetic peripheral neuropathy
8. Motor conduction velocity and the Hoffman reflex in diabetes
9. The Hoffmann reflex of human plantar foot muscles
10. Reappraisal of the electroneurographic and electromyographic diagnosis of diabetic peripheral neuropathy
11. Function of the neuromotor apparatus in diabetes mellitus
12. Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy
13. Diabetic autonomic neuropathy
14. Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood glow in rats with streptozotocin-induced diabetes
15. Neuropathy in experimental diabetes: An animal model
16. Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves
17. Peripheral nerves in early experimental diabetes: Expansion of the endoneurial space as a cause of increased water content
18. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response
19. Mechanisms of hyperkalemia associated with hyporeninemic hypoaldosteronism in streptozotocin-induced diabetic rats
20. Global burden of diabetes, 1995-2025
21. Ultrastructural, and morphometric analysis of skeletal muscle in a murine model of type I diabetes
22. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: Relationship to tests of neurological function
23. Nerve fibre studies in skin biopsies in peripheral neuropathies: Immunohistochemical analysis of neuropeptides in diabetes mellitus
24. Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan
25. Decreased accumulation of endogenous brain-derived neurotrophic factor against constricting sciatic nerve ligatures in streptozotocin-diabetic and galactose-fed rats
26. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats
27. The neuropathies associated with diabetes mellitus: A clinical and electromyographic study of 103 unselected diabetic patients
28. What is the best diagnostic index of conduction block and temporal dispersion?
29. Nerve conduction techniques
30. The effect of temporal dispersion on compound action potential area in human peripheral nerve
31. Natural history of peripheral neuropathy. I. Patients with non-insulin dependent diabetes mellitus
32. Functional analysis of the spinal cord monosynaptic apparatus in rats with manifest alloxan diabetes
33. Neuropathies associated with diabetes
34. Nerve biopsy findings in different patterns of proximal diabetic neuropathy
35. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus
36. Diabetic neuropathy: An update
37. Single-fiber study of contractile and biochemical properties of skeletal muscles in streptozotocin-induced diabetic rats
38. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects
39. Electrophysiological study of dorsal column function in streptozotocin-induced diabetic rats: Comparison with 2,5-hexanedione intoxication
40. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study
41. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: Ten-year follow-up from the diagnosis
42. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats
43. Morphological and morphometric study of peripheral nerves from rats with streptozotocin-induced diabetes mellitus
44. Tibial nerve somatosensory evoked potentials at various stages of peripheral neuropathy in insulin dependent diabetic patients
45. Evaluation of the functional state of the peripheral motor neuron apparatus in patients with diabetes mellitus